INTRODUCTION
Continuous subcutaneous insulin infusion (CSII) by means of an insulin pump is a sophisticated method for insulin substitution in persons with type 1 diabetes mellitus. Adequate basal rates (BR) and prandial boluses (PB) of the insulin pump are the main assumptions for successful treatment. Routinely, both BR and PB have been applied according to the results of frequent selfmonitoring of plasma glucose (SMPG) performed by means of a glucose meter (5-10 measurements per day). The Continuous Glucose Monitoring System (CGMS), registering 288 glucose concentrations per 24 hrs, seems to off er new ways for reaching optimum diabetes control 1-9, 11, 13, 15 .
AIM
The aim of the present pilot study was to assess whether in persons with type 1 diabetes mellitus treated by means of an insulin pump, the CGMS would enable appropriate adaptation of the BR and/or PB in order to decrease mean plasma glucose (MPG) in the course of 24-hour period and/or in basal (fasting) conditions in the night period.
MATERIALS AND METHODS
The study was designed and performed from January to April 2003.
Ten persons with type 1 diabetes mellitus (see Table 1 ) gave their informed consent according to the Declaration of Helsinki and entered the study.
Investigation of glucose concentrations
Glucose concentrations were investigated in interstitial fl uid (ISF-glucose) by means of the CGMS (Minimed-Med tronic) and in plasma (P-glucose) by means of a personal glucose meter Optium (Medisense-Abbot). The subcutaneously inserted sensor of the CGMS measured the electrical current that is related to interstitial glucose concentration. The assay method is based on electrochemical detection of glucose through its reaction with glucose oxidase. There is a good correlation between P-glucose (PG) and ISF-glucose 14 . Two CGMS monitors were used in the whole group. Each person was investigated by this means. The CGMS was calibrated every day according to PG values obtained from the glucose meter. Each person performed SMPG at least fi ve times a day. In this study, the ISF-glucose (CGMS) correlated well with P-glucose (Optium) for the whole fi ve-day period of investigation, i. e. not only for 3 days as stated in the literature 10 .
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Study design
The study design is shown in Fig. 1 .
c) Insertion of the sensor into the subcutaneous tissue of the abdomen about 5 cm from the umbilicus and at least 10 cm from the insertion of the insulin pump (Fig. 2 ). d) Sensor initialization. e) Following the successful initialization the tested person used the CGMS at home while maintaining his/her normal daily routine. a) Education of the tested person: on how to use the CGMS, how to keep to the study protocol (daily calibration of the sensor, alarms, frequency of SMPG at least fi ve times a day, standard meals containing 60 g of carbohydrates between 18:00 and 19:00 hrs followed by overnight fasting up to breakfast between 8:00 and 9:00 hrs, usual meals and muscular exercise during the day, registration of prandial boluses, hypoglycaemias, combatting hypoglycaemia by means of 250 ml of juice, and others) and how to record the important events in a diary and/or monitor 
A continuous glucose monitoring system (CGMS) -a promising approach for improving metabolic control in persons with type 1 diabetes mellitus treated by insulin pumps
Evaluation of the results
Comparisons of the obtained data (MPG, BR, PB and amount of carbohydrates in meals) were performed for the following periods of time: 1) Day 2 (00:00-24:00 hrs) versus day 4 (00:00-24:00 hrs).
2) The night from day 2 till day 3 (22:00-6:00 hrs) versus the night from day 4 till day 5 (22:00-6:00 hrs).
RESULTS
An overview of investigated parameters is shown in Table 2 and Table 3 .
Adaptations of insulin pump basal rates and prandial boluses based on two-day period of evaluation by means of the CGMS resulted in a decrease of MPG: A continuous glucose monitoring system (CGMS) -a promising approach for improving metabolic control in persons with type 1 diabetes mellitus treated by insulin pumps An increase of MPG was found: 1) In 3 out of 8 persons during the assessment of the 24-hour period. This was probably related to the increased amount of ingested carbohydrates and/or to contraregulation after hypoglycaemia which occurred even though insulin doses had been decreased. 2) In 2 out of 8 persons during the assessment of the night fasting period while continuing the intake of the same insulin doses.
Excluded persons: 1) During the assessment of the 24-hour period persons 4 and 7 were excluded due to transient disconnection of the cable on day 4. 2) During the assessment of the night fasting person 4 was excluded due to prolonged hypoglycaemia. Person 5 was excluded due to disconnection of the cable on day 5. 
DISCUSSION
In the course of the last thirty years continuous attempts have been made to develop an external closedloop system to enable adequate substitution of insulin in persons with type 1 diabetes mellitus. There are few problems with insulin pumps and, on the other hand, quality and lifetime of the glucose sensor and appropriate algorithm for insulin administration are the limiting factors. For this reason, we have tried to use the present devices (CGMS and insulin pumps), PC with respective software and our own experience as a "fair means" to improve diabetes control.
The limited number of patients does not allow us to do a statistical analysis. However, the presented case reports yield important information for further studies.
CONCLUSIONS
The CGMS is a useful means for assessment of effectiveness of basal rate and prandial boluses in persons with type 1 diabetes melittus treated by means of an insulin pump. Using the CGMS with an adaptation BR and PB based on two-day PG measurement resulted in MPG decrease in 5 out of 8 persons when assessing the 24-hour period, and in 6 out of 8 persons when assessing the night fasting period. MPG increased in 3 out of 8 persons when assessing the 24-hour period, and in 2 out of 8 persons when assessing the night fasting period. In these persons a fi nal correction of BR and PB was carried out. The effects will be monitored later on.
Further studies are necessary to adjust the algorithms for insulin substitution.
